What are the risks associated with using Enfamil (infant formula) AR (anti-reflux) for infants with reflux issues?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risks of Enfamil AR for Infants with Reflux

Enfamil AR formula is generally safe and effective as a first-line treatment for infants with reflux, with the main risks being constipation and potentially slower milk flow rates that may affect feeding in infants with coordination difficulties. 1

Safety Profile and Efficacy

Enfamil AR (Anti-Reflux) is a commercially available formula containing processed rice starch designed to reduce regurgitation in infants with gastroesophageal reflux (GER). The American Academy of Pediatrics and other pediatric gastroenterology societies recommend thickened formulas like Enfamil AR as part of the conservative management approach for infants with reflux symptoms 2, 1.

Benefits:

  • Reduces frequency of regurgitation and vomiting
  • May accelerate gastric emptying
  • Studies show resolution of cough symptoms in infants with reflux 2
  • Enfamil AR ready-to-feed formula is classified as "slightly thick" on the International Dysphagia Diet Standardisation Initiative (IDDSI) scale 3

Primary Risks:

  • Constipation: The most common side effect of rice-thickened formulas 1
  • Slower flow rates: Enfamil AR has significantly slower flow rates compared to standard formulas, which may affect feeding in infants with difficulty coordinating sucking, swallowing, and breathing 3
  • Increased caloric density: When rice cereal is added to formula, it increases caloric density to approximately 34 kcal/oz, which should be monitored for weight management 1

Important Considerations

When to Use Enfamil AR

Enfamil AR is appropriate for:

  • Infants with uncomplicated reflux symptoms (regurgitation, spitting up)
  • Formula-fed infants who haven't responded to basic feeding modifications
  • Infants with normal growth who need symptom management

When to Avoid Enfamil AR

Enfamil AR should be avoided in:

  • Preterm infants (<37 weeks gestation) due to risk of necrotizing enterocolitis 1
  • Infants with suspected cow's milk protein allergy (which can coexist with reflux in 42-58% of cases) 4
  • Infants with dysphagia or coordination difficulties who may struggle with the thicker formula 3

Proper Usage Guidelines

  1. Monitor for constipation: Watch for hard stools or decreased stool frequency
  2. Ensure proper nipple size: Due to the thicker consistency, infants may need a nipple with a larger hole to feed effectively
  3. Combine with other conservative measures:
    • Hold infant upright for 20-30 minutes after feeding
    • Feed smaller volumes more frequently
    • Avoid overfeeding

When to Consider Alternative Approaches

If symptoms persist despite using Enfamil AR:

  1. Consider evaluation for cow's milk protein allergy (symptoms may overlap with reflux) 1, 4
  2. Consider extensively hydrolyzed protein formula if allergy is suspected 1
  3. Consult pediatric gastroenterology if symptoms include:
    • Failure to thrive
    • Forceful vomiting
    • Feeding refusal
    • Respiratory complications
    • Blood in vomit or stool 1

Comparison to Medication Approaches

Thickened formulas like Enfamil AR are preferred over acid-suppressive medications (PPIs, H2 blockers) for uncomplicated reflux. Current guidelines discourage routine use of acid-suppressive medications for infant reflux due to:

  • Lack of proven efficacy in randomized controlled trials 5, 6
  • Potential adverse effects including increased risk of respiratory infections, gastroenteritis, and candidemia 2, 1
  • Overuse of PPIs in infants with reflux is a significant concern in pediatric practice 2, 1

Enfamil AR represents a safer first-line approach compared to pharmacological interventions for managing uncomplicated infant reflux.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.